期刊
AMERICAN JOURNAL OF PERINATOLOGY
卷 36, 期 12, 页码 1223-1228出版社
THIEME MEDICAL PUBL INC
DOI: 10.1055/s-0039-1683886
关键词
late preterm; sex differences; preterm birth; betamethasone; respiratory distress syndrome
Objective To estimate sex-specific differences in late preterm outcomes and evaluate whether betamethasone modifies this association. Study Design We conducted a secondary analysis of a multicenter trial of women at risk for late preterm birth randomized to receive betamethasone or placebo. We included women who delivered at 34 to 37 weeks and excluded major fetal anomalies. The primary outcome was severe neonatal morbidity (mechanical ventilation, respiratory distress syndrome, bronchopulmonary dysplasia, sepsis, necrotizing enterocolitis, and intraventricular hemorrhage). Maternal characteristics were compared using chi-square test, t -test, or Mann-Whitney U -test. Multivariable logistic regression estimated the association between sex and morbidity, and likelihood ratio testing assessed for effect modification by betamethasone. Results Of 2,831 women in the primary trial, 2,331 met the inclusion criteria: 1,236 delivered males and 1,095 delivered females. Betamethasone modified the association between sex and severe morbidity ( p = 0.047). Among those who received betamethasone, male sex was associated with higher odds of severe morbidity (adjusted odds ratio: 1.95, 95% confidence interval: 1.25-3.05), compared with female sex. Among those who did not receive betamethasone, there was no significant association between sex and morbidity. Conclusion Male sex is a risk factor for adverse late preterm outcomes, including severe neonatal morbidity after betamethasone receipt.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据